PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 11306421-8 2001 The soluble guanylyl cyclase inhibitor ODQ (10 micromol/L; n = 8) markedly reduced (P <0.01) the relaxations induced by TSV, ACh, glyceryl trinitrate, and bradykinin. 1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one 39-42 kininogen 1 Homo sapiens 158-168 15066907-8 2004 The guanylyl cyclase inhibitor ODQ and the NO scavenger hydroxocobalamin induced a larger shift of the bradykinin CRC than the NO synthase inhibitor L-NAME, although all three inhibitors equally suppressed bradykinin-induced cGMP responses. 1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one 31-34 kininogen 1 Homo sapiens 103-113 15066907-8 2004 The guanylyl cyclase inhibitor ODQ and the NO scavenger hydroxocobalamin induced a larger shift of the bradykinin CRC than the NO synthase inhibitor L-NAME, although all three inhibitors equally suppressed bradykinin-induced cGMP responses. 1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one 31-34 kininogen 1 Homo sapiens 206-216 10401557-15 1999 The ODQ potentiated hyperalgesia induced by carrageenan, bradykinin, TNF alpha, IL-1 beta, IL-6 and IL-8. 1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one 4-7 kininogen 1 Homo sapiens 57-67